Newsletter Subject

Guillain-Barre Syndrome Rates After RSV Shots in Sync With Trial Data, CDC Says

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Fri, May 31, 2024 10:47 PM

Email Preheader Text

Daily Headlines Friday, May 31, 2024 Today's Top Stories for {NAME} THE BREAK ROOM CME SPOTLIGHT THE

[MEDPAGE TODAY]( Daily Headlines Friday, May 31, 2024 Today's Top Stories for {NAME} [INFECTIOUS DISEASE]( [Guillain-Barre Syndrome Rates After RSV Shots in Sync With Trial Data, CDC Says]( [PSYCHIATRY]( [FDA Staff Questions Safety of MDMA Treatment for PTSD]( [INFECTIOUS DISEASE]( [FDA Approves First mRNA RSV Vaccine]( THE BREAK ROOM [Spell Check-Up: Try to Pass This Spelling Quiz]( CME SPOTLIGHT [Navigating CAR T-Cell Therapy for Non-Hodgkin Lymphoma in Community Practice]( [TRANSPLANTATION]( [Woman Is Back on Dialysis After Doctors Remove Transplanted Pig Kidney]( [GENETICS]( [A Single, Surprising Gene Behind a Disorder That Causes Intellectual Disability]( THE BREAK ROOM [Play Today’s Wordosis]( ADVERTISEMENT [INFECTIOUS DISEASE]( [COVID Shot After Acute Coronary Syndrome Might Not Prevent Further Events]( CME SPOTLIGHT [Empowering Patients in Their Beta Thalassemia Care: Strategies for Effective Transitions of Care and Shared Decision-Making]( [SPOTLIGHT ON]( [The Rocky Road to Safe, Effective Rotavirus Vaccines]( [ALLERGY & IMMUNOLOGY]( [Hereditary Angioedema Attacks Reduced With Donidalorsen Prophylaxis]( [ENDOCRINOLOGY]( [Tirzepatide Sheds Pounds in Chinese Adults With BMI as Low as 24]( THE BREAK ROOM [Wordectomy: Guess Today’s Medical Condition]( CME SPOTLIGHT [Navigating Transitions to Adult Care for Sickle Cell Disease: A Toolkit for Healthcare Providers and Their Patients]( [ONCOLOGY/HEMATOLOGY]( [Fewer Suicides in Cancer Patients; Circadian Rhythm Boost; HIV Vaccine for Cancer?]( [SPECIAL REPORTS]( [Urologists Flee Mission Health]( [ONCOLOGY/HEMATOLOGY]( [HPV Testing Outperforms Pap Smear for Detecting Cervical Cancer Precursor Lesions]( CME SPOTLIGHT [Mastering Mast Cell Mysteries: A Clinical Case Challenge in Recognizing and Managing Indolent Systemic Mastocytosis]( [RHEUMATOLOGY]( [In RA, Poorly Controlled Pain Portends Even More Serious Problems]( [SPOTLIGHT ON]( [Quadruplet Regimens Have Become Standard for Multiple Myeloma]( [SPOTLIGHT ON]( [Advances in CAR T-Cell Therapy for Multiple Myeloma]( CME SPOTLIGHT [Optimizing Treatment With Infusion-Based Therapies for HR+/HER2- and Triple-Negative Breast Cancer]( [MEETING COVERAGE]( [STAMP Inhibitor Tops Imatinib, Second-Gen TKIs for Newly Diagnosed CML]( [MEETING COVERAGE]( [Unprecedented PFS Results in ALK-Positive Lung Cancer Trial]( CME SPOTLIGHT [Moving the Needle: Adopting New Evidence Into the Lower-Risk Myelodysplastic Syndrome Treatment Paradigm]( # Weekly Survey [Is Your Practice Working Harder?]( Although practice costs went up last year, clinician pay rose because practices increased their productivity, a [Medical Group Management Association survey]( found.[VOTE >]( Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. [SEE ALL STORIES >]( Got a news tip? MedPage Today offers several ways to provide information to our journalists securely and confidentially. [LEARN MORE >]( [EVERYDAY HEALTH]( © 2024 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_Daily_DHE?xid=nl_mpt_DHE_2024-05-31&eun=g1020308d0r) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011

Marketing emails from medpagetoday.com

View More
Sent On

08/12/2024

Sent On

08/11/2024

Sent On

07/11/2024

Sent On

07/11/2024

Sent On

06/11/2024

Sent On

04/11/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.